Population Bio, Inc. (PB) is a privately held global gene discovery company leading the field of precision medicine. Built on extensive intellectual property, PB is empowering pharmaceutical companies to develop targeted therapies and companion diagnostics faster and more cost effectively. Addressing critical health concerns, PB's patented technology is currently used in collaborations and partnerships addressing complex neurological diseases, such as Autism, PML, Parkinson's and Alzheimer's, in addition to other common conditions having a genetic component such as endometriosis and peanut allergy.
When applied to drug discovery, the technology enables pharmaceutical companies to develop targeted therapies and companion diagnostics. PB's novel technology and exclusive products are primed to:
- Transform how physicians diagnose and manage disease in their patients
- Enable pharmaceutical companies to expand the number of available therapies and market drugs with higher efficacy and safety to improve healthcare for patients.